Major trends include automatic and closed-loop deep brain stimulation, rechargeable devices with longer battery life, and miniaturized DBS devices

Global Deep Brain Stimulation Market

Dublin, July 03, 2024 (GLOBE NEWSWIRE) — The report “Global Deep Brain Stimulation Market: Analysis by Product, Application, End-Use, Region Size, Trends and Forecast to 2029” has been added to Research & Marketing.com offering.

The global deep brain stimulation market was valued at USD 1.31 billion in 2023 and is expected to reach USD 2.56 billion by 2029. The market is expected to grow at a CAGR of 11.89% between 2024 and 2029.

Global Deep Brain Stimulation Market Dynamics

Growth factors: The global deep brain stimulation market growth is expected to be supported by numerous growth factors such as growth in geriatric population, increasing prevalence of neurological disorders, expanding indications for DBS, growing healthcare infrastructure, increasing demand for minimally invasive procedures, increasing awareness and acceptance, and regulatory approvals and funding, etc. Initially, DBS was mainly used for the treatment of Parkinson’s disease and essential tremor. However, ongoing studies and clinical trials have demonstrated its efficacy in treating a wider range of neurological and psychiatric conditions such as Tourette’s syndrome, chronic pain, depression, and even Alzheimer’s disease. This expansion in indications means that more patients with various conditions can benefit from DBS, thus increasing the overall market demand. Moreover, with the growing list of approved indications for DBS, insurance companies and national healthcare systems are more likely to cover these procedures. Expanded insurance reduces the financial burden on patients, making DBS more accessible and further boosting its market growth.

Challenges: However, the market growth would be negatively affected by various challenges such as potential side effects associated with DBS surgery, presence of alternative procedures, high costs, etc. The high costs of deep brain stimulation (DBS) procedures and devices pose a significant barrier to access, especially for patients from less affluent areas or those who do not have adequate insurance. The cost includes several components: the initial surgical implantation of the leads and neurostimulator; post-operative care, including monitoring and adjustment of stimulation settings; and potential surgeries to replace device components over time, as batteries and leads may need to be replaced periodically. These costs can add up significantly, making DBS a financially unviable option for many patients.

The story continues

Trends: The market is expected to grow at a rapid pace during the forecast period, owing to market trends such as telemedicine, automated deep brain stimulation, closed-loop brain stimulation, rechargeable devices with longer battery life, entry into emerging markets, miniaturized DBS devices, etc. The development of rechargeable DBS devices with longer battery life is a significant advancement in neurosurgery, offering improved patient outcomes, improved therapy management, reduced healthcare costs, convenience, and technological reliability. Traditional DBS devices often require surgical procedures to replace depleted batteries, usually every three to five years. However, rechargeable DBS systems significantly extend the battery life, sometimes lasting up to 15 years or more. This advancement reduces the frequency of replacement surgeries, lowering the risk of complications and associated healthcare costs. These devices are poised to expand DBS applications and further improve the quality of care for patients with neurological disorders.

Market segmentation analysis

By product: The dual-channel segment of the global deep brain stimulation (DBS) market accounts for the largest share and is expected to be the fastest growing due to its ability to offer enhanced therapeutic benefits through precise and configurable stimulation patterns across multiple brain regions. This capability is crucial for the effective treatment of complex neurological disorders such as Parkinson’s disease and essential tremor. Technological advances in dual-channel DBS systems, including improved implants and programming software, are further increasing their appeal to healthcare providers seeking optimal treatment outcomes for their patients.

By application: The Parkinson’s disease segment dominates the market due to its proven efficacy in relieving motor symptoms such as tremor, rigidity, and bradykinesia. The treatment’s success in improving patients’ quality of life and reducing drug dependence has led to its widespread adoption. On the other hand, epilepsy is expected to be the fastest growing segment during the forecast period due to several factors such as the increasing incidence of drug-resistant epilepsy cases worldwide, advances in neuroimaging techniques facilitating better patient selection for DBS, and the continued development of closed-loop DBS systems that can detect and respond to seizure activity in real time.

By end use: Hospitals accounted for the largest share of the market and are expected to be the fastest growing segment during the forecast period. Hospitals are equipped with specialized infrastructure and resources required to perform complex neurosurgical procedures such as DBS, facilitated by advanced operating rooms and highly trained teams of neurologists and neurosurgeons. They serve as central treatment centers for complex neurological conditions such as Parkinson’s disease and essential tremor, where DBS is a key treatment option. In addition, hospitals provide comprehensive care through integrated multidisciplinary teams, ensuring patients receive thorough assessment, precise surgical intervention, and ongoing treatment.

By region: North America is the largest region in the deep brain stimulation market and presents a promising landscape due to its advanced healthcare infrastructure, significant investment in medical research, and large patient population affected by neurological disorders. The region’s strong focus on technological innovation has led to the development of DBS devices with improved efficacy and safety profiles, such as improved targeting capabilities and longer battery life. Moreover, a favorable regulatory framework and solid reimbursement policies support the widespread adoption of DBS therapies. These factors combine to create a favorable environment for the growth of the DBS market in North America, making it a leader in both innovation and treatment outcomes for neurological and movement disorders.

Asia-Pacific stands out as the fastest growing region in the deep brain stimulation sector due to aging population, urbanization, and rising disposable income. The aging population is contributing to the rising prevalence of neurological disorders such as Parkinson’s disease and essential tremor, which is driving the demand for advanced treatment options such as DBS. Secondly, improving healthcare infrastructure and rising healthcare expenditure are increasing access to specialized neurological care, including DBS therapy. Thirdly, growing awareness among healthcare providers and patients about the efficacy of DBS in treating neurological conditions is accelerating adoption rates. Moreover, ongoing technological advancements and R&D investments are driving innovation in DBS technologies, which is further driving the market growth in the Asia-Pacific region.

Competitive Landscape and Recent Events

The global market is dominated by a few key companies due to their strong product portfolio and key strategic decisions. These include a group of 3 key companies with wider geographical presence and solid R&D, resulting in a strong product portfolio. The market is highly consolidated in nature, with three major players operating in the market, i.e. Boston Scientific Corp., Medtronic, and Abbott.

The key players in the global deep brain stimulation market are:

• Abbott

• Medtronic

• Boston Scientific

• Renisaw

• Zimmer Biomet

• Aleva Neurotherapy

• Noworoznika

• SceneRay Co. Ltd

Some of the strategies of key players in the market are new launches, mergers, acquisitions, and collaborations. In July 2023, Boston Scientific Corp. announced FDA clearance of its Vercise Neural Navigator 5 software. This software, when integrated with Vercise Genus DBS systems, is ready to provide physicians with the necessary data to optimize treatment for people living with Parkinson’s disease or essential tremor. Additionally, in September 2022, Aleva Neurotherapeutics received CE Mark approval for its magnetic resonance imaging (MRI) label for the directSTIM DBS system, allowing the use of this technology in a whole-body MRI environment throughout Europe.

Key Features:

Main topics:

1. Summary

2. Introduction

3. Global Market Analysis
3.1 Global Deep Brain Stimulation Market Analysis
3.2 Global Deep Brain Stimulation Market Analysis
3.3 Application Analysis of the Global Deep Brain Stimulation Market
3.4 Global Deep Brain Stimulation Market End-Use Analysis

4. Regional market analysis
4.1 North America Deep Brain Stimulation Market
4.2 Deep Brain Stimulation Market in Europe
4.3 Asia Pacific Deep Brain Stimulation Market
4.4 Rest of the World in the Deep Brain Stimulation Market

5. Impact of COVID-19

6. Market dynamics
6.1 Growth factors
6.1.1 Growth of the global geriatric population
6.1.2 Growing healthcare spending
6.1.3 Increasing incidence of neurological disorders
6.1.4 Expanding indications for DBS
6.1.5 Growing demand for minimally invasive surgery
6.1.6 Developing awareness and acceptance
6.1.7 Regulatory Approvals and Financing
6.2 Challenges
6.2.1 High medical costs
6.2.2 Risks of Deep Brain Stimulation
6.2.3 Presence of alternative procedures
6.3 Market trends
6.3.1 Telemedicine: Remote programming
6.3.2 Automatic Deep Brain Stimulation
6.3.3 Closed-loop deep brain stimulation
6.3.4 Cordless devices with longer battery life
6.3.5 Exploiting Emerging Markets
6.3.6 Miniaturized DBS Devices

7. Competitive Landscape
7.1 Global Deep Brain Stimulation Market: Competitive Landscape
7.2 Global Deep Brain Stimulation Market Players: Product Comparison

8. Company profiles

For more information on this report, please visit https://www.researchandmarkets.com/r/1zgy28

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900